JP2008013441A - Igf−1値上昇剤 - Google Patents
Igf−1値上昇剤 Download PDFInfo
- Publication number
- JP2008013441A JP2008013441A JP2006183234A JP2006183234A JP2008013441A JP 2008013441 A JP2008013441 A JP 2008013441A JP 2006183234 A JP2006183234 A JP 2006183234A JP 2006183234 A JP2006183234 A JP 2006183234A JP 2008013441 A JP2008013441 A JP 2008013441A
- Authority
- JP
- Japan
- Prior art keywords
- igf
- ovarian membrane
- value
- ingestion
- placebo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 101150088952 IGF1 gene Proteins 0.000 title 1
- 239000012528 membrane Substances 0.000 claims abstract description 49
- 230000002611 ovarian Effects 0.000 claims abstract description 48
- 230000003712 anti-aging effect Effects 0.000 claims abstract description 21
- 241000251468 Actinopterygii Species 0.000 claims abstract description 13
- 108091005804 Peptidases Proteins 0.000 claims abstract description 8
- 102000035195 Peptidases Human genes 0.000 claims description 7
- 241000239290 Araneae Species 0.000 claims description 3
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 abstract description 52
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 abstract description 52
- 239000003795 chemical substances by application Substances 0.000 abstract description 35
- 230000032683 aging Effects 0.000 abstract description 9
- 208000024891 symptom Diseases 0.000 abstract description 7
- 230000003247 decreasing effect Effects 0.000 abstract description 5
- 239000004365 Protease Substances 0.000 abstract 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- 230000037406 food intake Effects 0.000 description 27
- 239000000902 placebo Substances 0.000 description 26
- 229940068196 placebo Drugs 0.000 description 26
- 239000000706 filtrate Substances 0.000 description 11
- 235000019688 fish Nutrition 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- 241000972773 Aulopiformes Species 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 235000019515 salmon Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 235000010855 food raising agent Nutrition 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 210000001672 ovary Anatomy 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 238000004042 decolorization Methods 0.000 description 2
- 238000005238 degreasing Methods 0.000 description 2
- 238000004332 deodorization Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 238000000409 membrane extraction Methods 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000036962 time dependent Effects 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000005555 hypertensive agent Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Images
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
【解決手段】魚類の卵巣膜から抽出された成分を含む抗加齢剤であり、加齢により低下したIGF−1値を再び上昇させることができ、前記加齢に伴う諸症状を緩和、改善することができる。前記卵巣膜から抽出された成分は、該卵巣膜をタンパク分解酵素で処理することにより抽出された成分である。前記卵巣膜は、鮭の卵巣膜である。
【選択図】 図2
Description
〔比較例〕
本比較例では、まず、前記実施例の抗加齢剤に代えて、コーンスターチ125mg、乳糖125mgからなるプラセボ(偽薬)を、直径8mmの錠剤の形に製剤した。
〔比較例〕
本比較例では、まず、前記実施例のIGF−1値上昇剤に代えて、コーンスターチ125mg、乳糖125mgからなるプラセボ(偽薬)を、直径8mmの錠剤の形に製剤した。
次に、前記実施例とは異なる38〜42歳の健康な女性モニター10名に、前記偽薬のカプセル剤を1日当たり4錠、8週間に亘って投与した。尚、各モニターは、1ヶ月前からサプリメント、薬品(漢方薬を含む)の摂取を行っていない。
Claims (3)
- 魚類の卵巣膜から抽出された成分を含むことを特徴とする抗加齢剤。
- 請求項1記載の抗加齢剤において、前記卵巣膜から抽出された成分は、該卵巣膜をタンパク分解酵素で処理することにより抽出された成分であることを特徴とする抗加齢剤。
- 請求項1または請求項2記載の抗加齢剤において、前記卵巣膜は、鮭の卵巣膜であることを特徴とする抗加齢剤。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006183234A JP3946238B1 (ja) | 2006-07-03 | 2006-07-03 | Igf−1値上昇剤 |
KR1020070066257A KR101301037B1 (ko) | 2006-07-03 | 2007-07-02 | 항노화제 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006183234A JP3946238B1 (ja) | 2006-07-03 | 2006-07-03 | Igf−1値上昇剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP3946238B1 JP3946238B1 (ja) | 2007-07-18 |
JP2008013441A true JP2008013441A (ja) | 2008-01-24 |
Family
ID=38344678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006183234A Active JP3946238B1 (ja) | 2006-07-03 | 2006-07-03 | Igf−1値上昇剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3946238B1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010083762A (ja) | 2008-09-29 | 2010-04-15 | Kyowa Yakuhin Kk | 更年期障害改善剤及び栄養補助食品 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101450681B1 (ko) * | 2006-12-22 | 2014-10-14 | 가부시키가이샤 니폰 배리어 프리 | 화장료 |
JP4643754B1 (ja) * | 2010-07-02 | 2011-03-02 | 株式会社日本バリアフリー | 育毛剤 |
JP6085137B2 (ja) * | 2012-10-02 | 2017-02-22 | 株式会社日本バリアフリー | アンチエイジング剤 |
US9801404B2 (en) | 2012-12-26 | 2017-10-31 | Morinaga Milk Industry Co., Ltd. | IGF-1 production-promoting agent |
-
2006
- 2006-07-03 JP JP2006183234A patent/JP3946238B1/ja active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010083762A (ja) | 2008-09-29 | 2010-04-15 | Kyowa Yakuhin Kk | 更年期障害改善剤及び栄養補助食品 |
Also Published As
Publication number | Publication date |
---|---|
JP3946238B1 (ja) | 2007-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5887630B2 (ja) | ジペプチジルペプチダーゼ−iv阻害剤の製造方法 | |
TWI516280B (zh) | 紅藜萃取物用於製備促進膠原蛋白生成及抗皮膚老化之組合物之用途 | |
JP5916387B2 (ja) | ジペプチジルペプチダーゼ−4阻害剤 | |
JP3946238B1 (ja) | Igf−1値上昇剤 | |
WO2014017474A1 (ja) | コラーゲンペプチド組成物の製造方法、dpp-4阻害剤および血糖値上昇抑制剤 | |
JP5027001B2 (ja) | 酵素処理ローヤルゼリー及びそれを含有する皮膚繊維芽細胞の増殖促進剤 | |
JP4917584B2 (ja) | 可溶化蜂の子処理物、その製造方法、抗酸化剤、ace阻害剤、血圧降下剤、皮膚繊維芽細胞増殖促進剤、疲労回復剤、血流改善剤、並びに可溶化蜂の子処理物を含有する医薬品、化粧品又は飲食品 | |
JP3899116B1 (ja) | 肌荒れ改良剤 | |
KR102302933B1 (ko) | 마늘 혼합 발효물의 제조 및 심혈관 질환에 유효한 약학 조성물의 제조방법 | |
JP2008007417A5 (ja) | ||
KR20130006170A (ko) | CHP(cyclo(His-Pro))를 고농도로 함유한 대두 가수분해물을 포함하는 혈당 조절용 조성물 | |
JP3946239B1 (ja) | 加速度脈波加齢指数上昇剤 | |
JP2024072583A (ja) | Gabaを有効成分とする乳腺組織の健康維持剤 | |
JP2016164136A (ja) | 鰹節由来のジペプチジルペプチダーゼiv阻害組成物 | |
JP2008037770A (ja) | 抗加齢剤 | |
JP6456714B2 (ja) | 持久力向上剤 | |
JP6544503B2 (ja) | コラゲナーゼ阻害剤、並びにコラゲナーゼ阻害剤を配合した化粧料組成物及び機能性食品 | |
JP2005179235A (ja) | ローヤルゼリー又はその処理物の水溶性画分から得られる特定の分子量画分を有効成分とする気分の障害の予防、治療又は改善用組成物 | |
JP2011036241A (ja) | アンジオテンシン変換酵素阻害ペプチドの製造方法 | |
JP2010083762A (ja) | 更年期障害改善剤及び栄養補助食品 | |
JP2017195830A (ja) | 脂肪蓄積予防用の食品組成物 | |
WO2012133223A1 (ja) | 経口用マトリックスメタロプロテアーゼ(mmp)産生抑制剤 | |
JP6154029B2 (ja) | 睡眠改善剤、ノンレム睡眠時間増加剤及び鎮静剤 | |
JP5668018B2 (ja) | アルコール摂取障害予防剤 | |
JP6245924B2 (ja) | 血糖値上昇抑制剤、血糖値上昇抑制食品、及び血糖値上昇抑制化粧品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070320 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070410 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 3946238 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100420 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110420 Year of fee payment: 4 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120420 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130420 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140420 Year of fee payment: 7 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |